S U B J E C T I N D E X
761
Marker,
carmine as, 560
for cells, 517-18, 537
Mass-cultures,
development of, 8, 11
Mast cells,
corticotrophin and, 385
cortisone and, 385
heparin in, 358, 385
hyaluronic acid in, 358
metachromatic staining of, 358
and mucopolysaccharides, 163
neoplastic, 115
Matrix (Intercellular substances),
breakdown of, in cartilage, 309, 615,
647, 675
in cell aggregates, 494
development of, 476
and differentiation of epidermis, 479-80
D N A and, 60
in ear cartilage, and papain, 57
effect of, o n cell morphology, 159
as guiding agent for cells, 523
insulin and, 598-9
maintenance o f cartilage, 299
in making cell suspensions, 50, 368,
476
mechanocytes and production of, 163
metachromacy of, 476, 598, 612, 675-6
nature of, 57, 62
parathormone and, 645, 647
removal of, 476, 504, 615, 645, 647
sulphated, 372, 466
vitamin A and, 615, 675-6
vitamin G and, 687, 690
M B I I I cells,
sources o f carbohydrate for, 245-6
Mechanocytes, 146-8
and amoebocytes, compared, 162-4,
166
behaviour of, in a clot, 152
clones of, 47
and collagen, 163, 165
contact between, 164, 184
dependence of, on amoebocytes, 161
and intercellular matrix, 163
morphological types of, 159
movement of, 31, 153
nature o f isolated, 49
origin of, 161
pure strains of, 46
races of, 157
serum and, 32
M e d i a (see also Natural media, Synthetic
media), 99-132
adaptation of, 123-4
adaptation o f cells to, 121 et seq.
and cell aggregation, 493
conditioning of, 4 8 - 9 , 285, 4 7 4 - 5
for differentiation and function, 120,
470, 474
for mucopolysaccharide
production,
372-3
for proliferation, 120
reconditioning of, 128
selection o f suitable, 21
and somite development, 569
for special purposes, 130
-substratum interface, 4 9 3 - 4
for survival, 120
for suspension cultures, 126
table of, 118-19, 131
Media, T 8 , T 9 , 119, 128
M e d i u m 150 ( M l 5 0 ) , 109, 118
in nutritional studies, 298-9
M e d i u m 199, 103, 116, 119
development of, 109
supplemented for m a m m a r y glands,
127
and suspension cultures, 155
use of, 110
M e d i u m 752/1 ( M B 752/1), 119, 129,
470
M e d i u m 858, 117, 119, 122, 129
M e d i u m 1066 ( C M R L 1066), 116, 119,
147
M e d i u m BJG, 118, 129
M e d i u m B L . l , 118, 129
M e d i u m N G T G , 109 etc., 103, 110, 116,
118, 121-3
M e d i u m T A C P I , 119
for lymphoid tissue, 128
Medullary plate,
regions producing, 539
Meiosis, 208
abnormal, 412
chromosomes in, 439
imprecision of, 398
Melanin,
embryo extract and formation of, 644
formation inhibited b y phenylalanine,
306
sex hormones and, 609
thyroxine and formation of, 6 4 3 - 4
761
Marker,
carmine as, 560
for cells, 517-18, 537
Mass-cultures,
development of, 8, 11
Mast cells,
corticotrophin and, 385
cortisone and, 385
heparin in, 358, 385
hyaluronic acid in, 358
metachromatic staining of, 358
and mucopolysaccharides, 163
neoplastic, 115
Matrix (Intercellular substances),
breakdown of, in cartilage, 309, 615,
647, 675
in cell aggregates, 494
development of, 476
and differentiation of epidermis, 479-80
D N A and, 60
in ear cartilage, and papain, 57
effect of, o n cell morphology, 159
as guiding agent for cells, 523
insulin and, 598-9
maintenance o f cartilage, 299
in making cell suspensions, 50, 368,
476
mechanocytes and production of, 163
metachromacy of, 476, 598, 612, 675-6
nature of, 57, 62
parathormone and, 645, 647
removal of, 476, 504, 615, 645, 647
sulphated, 372, 466
vitamin A and, 615, 675-6
vitamin G and, 687, 690
M B I I I cells,
sources o f carbohydrate for, 245-6
Mechanocytes, 146-8
and amoebocytes, compared, 162-4,
166
behaviour of, in a clot, 152
clones of, 47
and collagen, 163, 165
contact between, 164, 184
dependence of, on amoebocytes, 161
and intercellular matrix, 163
morphological types of, 159
movement of, 31, 153
nature o f isolated, 49
origin of, 161
pure strains of, 46
races of, 157
serum and, 32
M e d i a (see also Natural media, Synthetic
media), 99-132
adaptation of, 123-4
adaptation o f cells to, 121 et seq.
and cell aggregation, 493
conditioning of, 4 8 - 9 , 285, 4 7 4 - 5
for differentiation and function, 120,
470, 474
for mucopolysaccharide
production,
372-3
for proliferation, 120
reconditioning of, 128
selection o f suitable, 21
and somite development, 569
for special purposes, 130
-substratum interface, 4 9 3 - 4
for survival, 120
for suspension cultures, 126
table of, 118-19, 131
Media, T 8 , T 9 , 119, 128
M e d i u m 150 ( M l 5 0 ) , 109, 118
in nutritional studies, 298-9
M e d i u m 199, 103, 116, 119
development of, 109
supplemented for m a m m a r y glands,
127
and suspension cultures, 155
use of, 110
M e d i u m 752/1 ( M B 752/1), 119, 129,
470
M e d i u m 858, 117, 119, 122, 129
M e d i u m 1066 ( C M R L 1066), 116, 119,
147
M e d i u m BJG, 118, 129
M e d i u m B L . l , 118, 129
M e d i u m N G T G , 109 etc., 103, 110, 116,
118, 121-3
M e d i u m T A C P I , 119
for lymphoid tissue, 128
Medullary plate,
regions producing, 539
Meiosis, 208
abnormal, 412
chromosomes in, 439
imprecision of, 398
Melanin,
embryo extract and formation of, 644
formation inhibited b y phenylalanine,
306
sex hormones and, 609
thyroxine and formation of, 6 4 3 - 4